The DOI matches its Crossref record; 302 of the 302 references it cites were found in a registry or an index.
Industrial natural product chemistry for drug discovery and development
Abstract
Covering: up to March 2013. In addition to their prominent role in basic biological and chemical research, natural products are a rich source of commercial products for the pharmaceutical and other industries. Industrial natural product chemistry is of fundamental importance for successful product development, as the vast majority (ca. 80%) of commercial drugs derived from natural products require synthetic efforts, either to enable economical access to bulk material, and/or to optimize drug properties through structural modifications. This review aims to illustrate issues on the pathway from lead to product, and how they have been successfully addressed by modern natural product chemistry. It is focused on natural products of current relevance that are, or are intended to be, used as pharmaceuticals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
High-level semi-synthetic production of the potent antimalarial artemisinin
Paddon, C. J., Westfall, P. J., Pitera, D. J., Benjamin, K., Fisher, K., McPhee, D., Leavell, M. D., Tai, A., Main, A., Eng, D., et al. (2013) · Nature · doi:10.1038/nature12051 · Cited by 2,060
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,006
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
VÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
Lewis Phillips, G. D., Li, G., Dugger, D. L., Crocker, L. M., Parsons, K. L., Mai, E., Blättler, W. A., Lambert, J. M., Chari, R. V. J., Lutz, R. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1776 · Cited by 1,676
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Schreiber, S. L. (1991) · Science · doi:10.1126/science.1702904 · Cited by 1,494
The Biosynthetic Logic of Polyketide Diversity
Hertweck, C. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806121 · Cited by 1,346
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Meier, J. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.140 · Cited by 1,311
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt832 · Cited by 1,206
Drug development from marine natural products
Molinski, T. F., Dalisay, D. S., Lievens, S. L., & Saludes, J. P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2487 · Cited by 1,186
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Cortes, J., O'Shaughnessy, J., Loesch, D., Blum, J. L., Vahdat, L. T., Petrakova, K., Chollet, P., Manikas, A., Diéras, V., Delozier, T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60070-6 · Cited by 1,094
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Expression cloning and cDNA sequencing of the Na+/glucose co-transporter
Hediger, M. A., Coady, M. J., Ikeda, T. S., & Wright, E. M. (1987) · Nature · doi:10.1038/330379a0 · Cited by 1,004
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
Rapamycin passes the torch: a new generation of mTOR inhibitors
Benjamin, D., Colombi, M., Moroni, C., & Hall, M. N. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3531 · Cited by 989
Qinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950
SEHGAL, S. N., BAKER, H., & VÉZINA, C. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.727 · Cited by 947
Ehrenkranz, J. R. L., Lewis, N. G., Ronald Kahn, C., & Roth, J. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.532 · Cited by 930
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Treatment of HER2-positive breast cancer: current status and future perspectives
Arteaga, C. L., Sliwkowski, M. X., Osborne, C. K., Perez, E. A., Puglisi, F., & Gianni, L. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.177 · Cited by 861
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Bross, P. F., Beitz, J. G., Chen, G., Chen, X., Duffy, E. J., Kieffer, L. V., Roy, S., Sridhara, R. N., Rahman, A., Williams, G., et al. (2001) · PubMed · Cited by 855
Göke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., & Göke, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36565-2 · Cited by 837
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
SGLT2 inhibition — a novel strategy for diabetes treatment
Chao, E. C., & Henry, R. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3180 · Cited by 822
Rossetti, L., Smith, D., Shulman, G. I., Papachristou, D., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112981 · Cited by 809
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Chun, J., & Hartung, H.-P. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181cbf825 · Cited by 796
Senter, P. D., & Sievers, E. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2289 · Cited by 763
Peptide Neurotoxins from Fish-Hunting Cone Snails
Olivera, B. M., Gray, W. R., Zeikus, R., McIntosh, J. M., Varga, J., Rivier, J., de Santos, V., & Cruz, L. J. (1985) · Science · doi:10.1126/science.4071055 · Cited by 747
Creutzfeldt, W. (1979) · Diabetologia · doi:10.1007/bf01225454 · Cited by 731
Das Neves Gomes, C., Jacquet, O., Villiers, C., Thuéry, P., Ephritikhine, M., & Cantat, T. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201106864 · Cited by 695
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672
Sehgal, S. N. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00045-9 · Cited by 663
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Bugg, T. D. H., Wright, G. D., Dutka-Malen, S., Arthur, M., Courvalin, P., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 650
Meng, W., Ellsworth, B. A., Nirschl, A. A., McCann, P. J., Patel, M., Girotra, R. N., Wu, G., Sher, P. M., Morrison, E. P., Biller, S. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701272q · Cited by 634
Kanai, Y., Lee, W. S., You, G., Brown, D., & Hediger, M. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116972 · Cited by 630
Chiba, K., Yanagawa, Y., Masubuchi, Y., Kataoka, H., Kawaguchi, T., Ohtsuki, M., & Hoshino, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.5037 · Cited by 596
The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10
Pettit, G. R., Kamano, Y., Herald, C. L., Tuinman, A. A., Boettner, F. E., Kizu, H., Schmidt, J. M., Baczynskyj, L., Tomer, K. B., & Bontems, R. J. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00256a070 · Cited by 583
FUJITA, T., INOUE, K., YAMAMOTO, S., IKUMOTO, T., SASAKI, S., TOYAMA, R., CHIBA, K., HOSHINO, Y., & OKUMOTO, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.208 · Cited by 540
A Medicinal Chemistry Perspective on Artemisinin and Related Endoperoxides
O'Neill, P. M., & Posner, G. H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030571c · Cited by 538
Halichondrins-antitumor polyether macrolides from a marine sponge
Hirata, Y., & Uemura, D. (1986) · Pure and Applied Chemistry · doi:10.1351/pac198658050701 · Cited by 519
Continuous‐Flow Synthesis of the Anti‐Malaria Drug Artemisinin
Lévesque, F., & Seeberger, P. H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107446 · Cited by 516
The incretin system and its role in type 2 diabetes mellitus
HOLST, J., VILSBOLL, T., & DEACON, C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.012 · Cited by 515
AUREOMYCIN: A PRODUCT OF THE CONTINUING SEARCH FOR NEW ANTIBIOTICS
Duggar, B. M. (1948) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1948.tb27262.x · Cited by 512
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Rinehart, K. L., Holt, T. G., Fregeau, N. L., Stroh, J. G., Keifer, P. A., Sun, F., Li, L. H., & Martin, D. G. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00302a007 · Cited by 492
Jordan, M. A., Kamath, K., Manna, T., Okouneva, T., Miller, H. P., Davis, C., Littlefield, B. A., & Wilson, L. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0345 · Cited by 489
RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
Chiu, M. I., Katz, H., & Berlin, V (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12574 · Cited by 481
Brinkmann, V., Cyster, J. G., & Hla, T. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00476.x · Cited by 478
The Vancomycin Group of Antibiotics and the Fight against Resistant Bacteria
Williams, D. H., & Bardsley, B. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990503)38:9<1172::aid-anie1172>3.0.co;2-c · Cited by 468
Comprehensive medicinal chemistry II
Taylor, J. B. (2007) · Cited by 468
Inhibition of the immune response by rapamycin, a new antifungal antibiotic
Martel, R. R., Klicius, J., & Galet, S. (1977) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y77-007 · Cited by 463
Vilsbøll, T., Agersø, H., Krarup, T., & Holst, J. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021053 · Cited by 444
LoRusso, P. M., Weiss, D., Guardino, E., Girish, S., & Sliwkowski, M. X. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0762 · Cited by 444
Pham, T. H. M., Baluk, P., Xu, Y., Grigorova, I., Bankovich, A. J., Pappu, R., Coughlin, S. R., McDonald, D. M., Schwab, S. R., & Cyster, J. G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091619 · Cited by 444
Artemisinin: Discovery from the Chinese Herbal Garden
Miller, L. H., & Su, X. (2011) · Cell · doi:10.1016/j.cell.2011.08.024 · Cited by 436
Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1127-1134.2005 · Cited by 425
Total synthesis of halichondrin B and norhalichondrin B
Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400
Nomura, S., Sakamaki, S., Hongu, M., Kawanishi, E., Koga, Y., Sakamoto, T., Yamamoto, Y., Ueta, K., Kimata, H., Nakayama, K., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100332n · Cited by 385
Bai, R. L., Paull, K. D., Herald, C. L., Malspeis, L., Pettit, G. R., & Hamel, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98491-7 · Cited by 379
ANTIBIOTICS THAT INHIBIT FUNGAL CELL WALL DEVELOPMENT
Debono, M., & Gordee, R. S. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.002351 · Cited by 372
Echinocandin Antifungal Drugs in Fungal Infections: A Comparison
Chen, S. C.-A., Slavin, M. A., & Sorrell, T. C. (2011) · Drugs · doi:10.2165/11585270-000000000-00000 · Cited by 371
Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
Mullershausen, F., Zecri, F., Cetin, C., Billich, A., Guerini, D., & Seuwen, K. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.173 · Cited by 370
The discovery and development of marine compounds with pharmaceutical potential
Munro, M. H. G., Blunt, J. W., Dumdei, E. J., Hickford, S. J. H., Lill, R. E., Li, S., Battershill, C. N., & Duckworth, A. R. (1999) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00052-8 · Cited by 369
RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTING
Calne, R. Y., Lim, S., Samaan, A., Collier, D. S. J., Pollard, S. G., White, D. J. G., & Thiru, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90417-0 · Cited by 367
The Biosynthesis of Artemisinin (Qinghaosu) and the Phytochemistry of Artemisia annua L. (Qinghao)
Brown, G. D. (2010) · Molecules · doi:10.3390/molecules15117603 · Cited by 363
Tsuruta, H., Paddon, C. J., Eng, D., Lenihan, J. R., Horning, T., Anthony, L. C., Regentin, R., Keasling, J. D., Renninger, N. S., & Newman, J. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004489 · Cited by 363
Ziconotide for treatment of severe chronic pain
Schmidtko, A., Lötsch, J., Freynhagen, R., & Geisslinger, G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60354-6 · Cited by 356
Enantioselective Total Synthesis of Ecteinascidin 743
Corey, E. J., Gin, D. Y., & Kania, R. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja962480t · Cited by 352
Activity of rapamycin (AY-22,989) against transplanted tumors.
ENG, C. P., SEHGAL, S. N., & VEZINA, C. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1231 · Cited by 351
Recent Developments in the Maytansinoid Antitumor Agents
Cassady, J. M., Chan, K. K., Floss, H. G., & Leistner, E. (2004) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.52.1 · Cited by 342
Steiner, J. P., Connolly, M. A., Valentine, H. L., Hamilton, G. S., Dawson, T. M., Hester, L., & Snyder, S. H. (1997) · Nature Medicine · doi:10.1038/nm0497-421 · Cited by 341
Antimitotic Activity of the Potent Tumor Inhibitor Maytansine
Remillard, S., Rebhun, L. I., Howie, G. A., & Kupchan, S. M. (1975) · Science · doi:10.1126/science.1241159 · Cited by 337
Schmid, G., & Hofheinz, W. (1983) · Journal of the American Chemical Society · doi:10.1021/ja00341a054 · Cited by 329
Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
Cuevas, C., & Francesch, A. (2009) · Natural Product Reports · doi:10.1039/b808331m · Cited by 323
Fingolimod for Multiple Sclerosis
Pelletier, D., & Hafler, D. A. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1101691 · Cited by 315
Semisynthetic Maytansine Analogues for the Targeted Treatment of Cancer
Widdison, W. C., Wilhelm, S. D., Cavanagh, E. E., Whiteman, K. R., Leece, B. A., Kovtun, Y., Goldmacher, V. S., Xie, H., Steeves, R. M., Lutz, R. J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060319f · Cited by 309
A Convergent Enantioselective Route to Structurally Diverse 6-Deoxytetracycline Antibiotics
Charest, M. G., Lerner, C. D., Brubaker, J. D., Siegel, D. R., & Myers, A. G. (2005) · Science · doi:10.1126/science.1109755 · Cited by 298
Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine
Sheldrick, G. M., Jones, P. G., Kennard, O., Williams, D. H., & Smith, G. A. (1978) · Nature · doi:10.1038/271223a0 · Cited by 297
Maturing antibody–drug conjugate pipeline hits 30
Mullard, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4009 · Cited by 295
Norhalichondrin A: an antitumor polyether macrolide from a marine sponge
Uemura, D., Takahashi, K., Yamamoto, T., Katayama, C., Tanaka, J., Okumura, Y., & Hirata, Y. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00302a042 · Cited by 289
Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia.
Lyons, W. E., George, E. B., Dawson, T. M., Steiner, J. P., & Snyder, S. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3191 · Cited by 285
Synthesis of Ecteinascidin ET-743 and Phthalascidin Pt-650 from Cyanosafracin B
Cuevas, C., Pérez, M., Martín, M. J., Chicharro, J. L., Fernández-Rivas, C., Flores, M., Francesch, A., Gallego, P., Zarzuelo, M., de la Calle, F., et al. (2000) · Organic Letters · doi:10.1021/ol0062502 · Cited by 282
Antibiotics in the clinical pipeline in 2011
Butler, M. S., & Cooper, M. A. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.44 · Cited by 272
Lee, W. S., Kanai, Y., Wells, R. G., & Hediger, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32677-7 · Cited by 268
Total Syntheses of Vancomycin and Eremomycin Aglycons
Evans, D. A., Wood, M. R., Trotter, B. W., Richardson, T. I., Barrow, J. C., & Katz, J. L. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981016)37:19<2700::aid-anie2700>3.0.co;2-p · Cited by 268
Immunoconjugates containing novel maytansinoids: promising anticancer drugs.
CHARI, R. V. J., Martell, B., Gross, J. L., Cook, S., Shah, S. A., Blättler, W. A., McKenzie, S. J., & Goldmacher, V. S. (1992) · PubMed · Cited by 266
Benz, F., Knüsel, F., Nüesch, J., Treichler, H., Voser, W., Nyfeler, R., & Keller‐Schierlein, W. (1974) · Helvetica Chimica Acta · doi:10.1002/hlca.19740570818 · Cited by 253
The Impact of Bacterial Genomics on Natural Product Research
Bode, H. B., & Müller, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501080 · Cited by 253
Valentino, K., Newcomb, R., Gadbois, T., Singh, T., Bowersox, S., Bitner, S., Justice, A., Yamashiro, D., Hoffman, B. B., & Ciaranello, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7894 · Cited by 249
Homology of the human intestinal Na+/glucose and Escherichia coli Na+/proline cotransporters.
Hediger, M. A., Turk, E., & Wright, E. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5748 · Cited by 242
Alvarado, F., & Crane, R. K. (1962) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(62)90543-7 · Cited by 239
Lopus, M., Oroudjev, E., Wilson, L., Wilhelm, S., Widdison, W., Chari, R., & Jordan, M. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0644 · Cited by 232
Akt inhibitors in clinical development for the treatment of cancer
Pal, S. K., Reckamp, K., Yu, H., & Figlin, R. A. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.520701 · Cited by 226
A Continuous‐Flow Process for the Synthesis of Artemisinin
Kopetzki, D., Lévesque, F., & Seeberger, P. H. (2013) · Chemistry – A European Journal · doi:10.1002/chem.201204558 · Cited by 218
Kataoka, H., Sugahara, K., Shimano, K., Teshima, K., Koyama, M., Fukunari, A., & Chiba, K. (2005) · PubMed · Cited by 216
Glycopeptide Antibiotics: from Conventional Molecules to New Derivatives
Van Bambeke, F., Van Laethem, Y., Courvalin, P., & Tulkens, P. M. (2004) · Drugs · doi:10.2165/00003495-200464090-00001 · Cited by 213
de Claro, R. A., McGinn, K., Kwitkowski, V., Bullock, J., Khandelwal, A., Habtemariam, B., Ouyang, Y., Saber, H., Lee, K., Koti, K., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1803 · Cited by 210
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
Zhou, Q., Lui, V. W., & Yeo, W. (2011) · Future Oncology · doi:10.2217/fon.11.95 · Cited by 210
Gibbons, J. J., Abraham, R. T., & Yu, K. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.10.011 · Cited by 208
SIROLIMUS: A POTENT NEW IMMUNOSUPPRESSANT FOR LIVER TRANSPLANTATION
Watson, C. J. E., Friend, P. J., Jamieson, N. V., Frick, T. W., Alexander, G., Gimson, A. E., & Calne, R. (1999) · Transplantation · doi:10.1097/00007890-199902270-00002 · Cited by 204
Molecular Characteristics of Na+-coupled Glucose Transporters in Adult and Embryonic Rat Kidney
You, G., Lee, W.-S., Barros, E. J. G., Kanai, Y., Huo, T.-L., Khawaja, S., Wells, R. G., Nigam, S. K., & Hediger, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29365 · Cited by 201
Strader, C. R., Pearce, C. J., & Oberlies, N. H. (2011) · Journal of Natural Products · doi:10.1021/np2000528 · Cited by 196
Pettit, G. R., Herald, C. L., Boyd, M. R., Leet, J. E., Dufresne, C., Doubek, D. L., Schmidt, J. M., Cerny, R. L., Hooper, J. N. A., & Rutzler, K. C. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00115a027 · Cited by 191
Nicolaou, K. C., Mitchell, H. J., Jain, N. F., Winssinger, N., Hughes, R. O., & Bando, T. (1999) · Angewandte Chemie International Edition · Cited by 187
EFFECT OF DIABETES AND INSULIN ON THE MAXIMUM CAPACITY OF THE RENAL TUBULES TO REABSORB GLUCOSE 1
Farber, S. J., Berger, E. Y., & Earle, D. P. (1951) · Journal of Clinical Investigation · doi:10.1172/jci102424 · Cited by 185
Drucker, D. J., Dritselis, A., & Kirkpatrick, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3148 · Cited by 181
Pettit, G. R., Singh, S. B., Hogan, F., Lloyd-Williams, P., Herald, D. L., Burkett, D. D., & Clewlow, P. J. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00196a061 · Cited by 177
Ohtake, Y., Sato, T., Kobayashi, T., Nishimoto, M., Taka, N., Takano, K., Yamamoto, K., Ohmori, M., Yamaguchi, M., Takami, K., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300884k · Cited by 174
Kirschning, A., & Hahn, F. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107386 · Cited by 169
Sakai, R., Rinehart, K. L., Guan, Y., & Wang, A. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11456 · Cited by 167
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
Furman, B. L. (2012) · Toxicon · doi:10.1016/j.toxicon.2010.12.016 · Cited by 166
Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation.
BAKER, H., SIDOROWICZ, A., SEHGAL, S. N., & VÉZINA, C. (1978) · The Journal of Antibiotics · doi:10.7164/antibiotics.31.539 · Cited by 166
Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)
LEADBETTER, M. R., ADAMS, S. M., BAZZINI, B., FATHEREE, P. R., KARR, D. E., KRAUSE, K. M., LAM, B. M. T., LINSELL, M. S., NODWELL, M. B., PACE, J. L., et al. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.326 · Cited by 165
Macrocyclic ketone analogues of halichondrin B
Zheng, W., Seletsky, B. M., Palme, M. H., Lydon, P. J., Singer, L. A., Chase, C. E., Lemelin, C. A., Shen, Y., Davis, H., Tremblay, L., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.069 · Cited by 163
Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic
Grossman, T. H., Starosta, A. L., Fyfe, C., O'Brien, W., Rothstein, D. M., Mikolajka, A., Wilson, D. N., & Sutcliffe, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06187-11 · Cited by 162
Washburn, W. N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013019 · Cited by 160
Suzuki, M., Honda, K., Fukazawa, M., Ozawa, K., Hagita, H., Kawai, T., Takeda, M., Yata, T., Kawai, M., Fukuzawa, T., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.191593 · Cited by 158
The State of the Art in Anti-Malarial Drug Discovery and Development
Burrows, J. N., Chibale, K., & Wells, T. N. C. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795429194 · Cited by 157
Functional genomics and the biosynthesis of artemisinin
Covello, P. S., Teoh, K. H., Polichuk, D. R., Reed, D. W., & Nowak, G. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.02.016 · Cited by 152
THE ACTION OF PHLORIZIN ON THE EXCRETION OF GLUCOSE, XYLOSE, SUCROSE, CREATININE AND UREA BY MAN
Chasis, H., Jolliffe, N., & Smith, H. W. (1933) · Journal of Clinical Investigation · doi:10.1172/jci100559 · Cited by 152
Jackson, K. L., Henderson, J. A., & Phillips, A. J. (2009) · Chemical Reviews · doi:10.1021/cr900016w · Cited by 152
Development of Na+-dependent hexose transport in a cultured line of porcine kidney cells
Amsler, K., & Cook, J. S. (1982) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1982.242.1.c94 · Cited by 149
Deng, C., Pan, B.-Q., & O’Connor, O. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0290 · Cited by 148
Total Synthesis of the Antimalarial Sesquiterpene Peroxide Qinghaosu and Yingzhaosu A
Zhou, W.-S., & Xu, X.-X. (1994) · Accounts of Chemical Research · doi:10.1021/ar00043a005 · Cited by 147
Crowley, B. M., & Boger, D. L. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0572912 · Cited by 145
Natural products and Pharma 2011: Strategic changes spur new opportunities
Carter, G. T. (2011) · Natural Product Reports · doi:10.1039/c1np00033k · Cited by 144
Conotoxins: natural product drug leads
Halai, R., & Craik, D. J. (2009) · Natural Product Reports · doi:10.1039/b819311h · Cited by 142
ATP-Competitive Inhibitors of mTOR: An Update
Schenone, S., Brullo, C., Musumeci, F., Radi, M., & Botta, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391651 · Cited by 142
Towle, M. J., Salvato, K. A., Wels, B. F., Aalfs, K. K., Zheng, W., Seletsky, B. M., Zhu, X., Lewis, B. M., Kishi, Y., Yu, M. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1874 · Cited by 141
PI3Kδ Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic
Fruman, D. A., & Rommel, C. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0249 · Cited by 141
Xie, J. H., Pierce, J. G., James, R. C., Okano, A., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207142h · Cited by 140
Kennedy, J. (2007) · Natural Product Reports · doi:10.1039/b707678a · Cited by 140
Xie, J. H., Okano, A., Pierce, J. G., James, R. C., Stamm, S., Crane, C. M., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja209937s · Cited by 138
Insights into the pharmacological relevance of lysophospholipid receptors
Mutoh, T., Rivera, R. R., & Chun, J. J. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01622.x · Cited by 137
A simple conversion of artemisinic acid into artemisinin
Roth, R. J., & Acton, N. (1989) · Journal of Natural Products · doi:10.1021/np50065a050 · Cited by 136
The X-ray crystal structure of rapamycin, C 51 H 79 NO 13
Swindells, D. C. N., White, P. S., & Findlay, J. A. (1978) · Canadian Journal of Chemistry · doi:10.1139/v78-407 · Cited by 136
Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
Kim, S. J., Cegelski, L., Stueber, D., Singh, M., Dietrich, E., Tanaka, K. S. E., Parr, T. R., Far, A. R., & Schaefer, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.031 · Cited by 134
A Robust Platform for the Synthesis of New Tetracycline Antibiotics
Sun, C., Wang, Q., Brubaker, J. D., Wright, P. M., Lerner, C., Noson, K., Charest, M. G., Siegel, D. R., Wang, Y.-M., & Myers, A. G. (2008) · Journal of the American Chemical Society · doi:10.1021/ja806629e · Cited by 134
Imamura, M., Nakanishi, K., Suzuki, T., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.051 · Cited by 134
Diastereoselective Total Synthesis of the Vancomycin Aglycon with Ordered Atropisomer Equilibrations
Boger, D. L., Miyazaki, S., Kim, S. H., Wu, J. H., Loiseleur, O., & Castle, S. L. (1999) · Journal of the American Chemical Society · doi:10.1021/ja990189i · Cited by 133
Hale, V., Keasling, J. D., Renninger, N. S., & Diagana, T. T. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.198 · Cited by 132
Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats.
Xiao, W. H., & Bennett, G. J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10579-x · Cited by 131
Mendola, D. (2003) · Biomolecular Engineering · doi:10.1016/s1389-0344(03)00075-3 · Cited by 130
Covello, P. S. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2008.10.001 · Cited by 127
Pneumocandins from Zalerion arboricola. I. Discovery and isolation.
Schwartz, R. E., Sesin, D. F., JOSHUA, H., et al. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1853 · Cited by 127
Xiao, X.-Y., Hunt, D. K., Zhou, J., Clark, R. B., Dunwoody, N., Fyfe, C., Grossman, T. H., O’Brien, W. J., Plamondon, L., Rönn, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201465w · Cited by 126
From natural products to clinically useful antifungals
Barrett, D. G. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00085-6 · Cited by 126
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
Abdul‐Ghani, M. A., Norton, L., & DeFronzo, R. A. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0275-6 · Cited by 123
Microbial production of isoprenoids
Chandran, S. S., Kealey, J. T., & Reeves, C. D. (2011) · Process Biochemistry · doi:10.1016/j.procbio.2011.05.012 · Cited by 123
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
Tsujihara, K., Hongu, M., SAITO, K., Kawanishi, H., Kuriyama, K., Matsumoto, M., Oku, A., Ueta, K., Tsuda, M., & Saito, A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990175n · Cited by 123
Raufman, J., Singh, L., Singh, G., & Eng, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36628-1 · Cited by 122
On the chemistry and high field nuclear magnetic resonance spectroscopy of rapamycin
Findlay, J. A., & Radics, L. (1980) · Canadian Journal of Chemistry · doi:10.1139/v80-090 · Cited by 121
Functional Genomics and the Biosynthesis of Artemisinin
Covello, P. S., Teoh, K. H., Polichuk, D. R., Reed, D. W., & Nowak, G. (2007) · ChemInform · doi:10.1002/chin.200742266 · Cited by 121
van der Velden, V. H. J., Boeckx, N., Jedema, I., Marvelde, J. G. T., Hoogeveen, P. G., Boogaerts, M. A., & van Dongen, J. J. M. (2004) · Leukemia · doi:10.1038/sj.leu.2403350 · Cited by 119
Dabydeen, D. A., Burnett, J. C., Bai, R., Verdier‐Pinard, P., Hickford, S. J. H., Pettit, G. R., Blunt, J. W., Munro, M. H. G., Gussio, R., & Hamel, E. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026641 · Cited by 119
Debono, M., Turner, W. W., LaGrandeur, L., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00017a012 · Cited by 114
Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy
Ingwersen, J., Aktaş, O., Küry, P., Kieseier, B. C., Boyко, A., & Hartung, H. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.05.005 · Cited by 113
Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives
Bouffard, F. A., Zambias, R. A., Dropinski, J. F., Balkovec, J. M., Hammond, M. L., Abruzzo, G. K., Bartizal, K. F., Marrinan, J. A., & Kurtz, M. B. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00028a003 · Cited by 113
Tahara, A., Kurosaki, E., Yokono, M., Yamajuku, D., Kihara, R., Hayashizaki, Y., Takasu, T., Imamura, M., Li, Q., Tomiyama, H., et al. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0713-z · Cited by 112
Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer
Burris, H. A., Tibbitts, J., Holden, S. N., Sliwkowski, M. X., & Phillips, G. D. L. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.03.018 · Cited by 112
Ruan, B. H., Pong, K., Jow, F., Bowlby, M. R., Crozier, R. A., Liu, D., Shi, L., Chen, Y., Mercado, M. L. T., Feng, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710424105 · Cited by 112
Pettit, G. R., Tan, R., Gao, F., et al. (1993) · The Journal of Organic Chemistry · doi:10.1021/jo00061a030 · Cited by 112
IWAMOTO, T., Fujie, A., Sakamoto, K., TSURUMI, Y., Shigematsu, N., Yamashita, M., HASHIMOTO, S., OKUHARA, M., & KOHSAKA, M. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.1084 · Cited by 111
Food-drugs from the sea : proceedings
Youngken, H. W., & Worthen, L. R. (1970) · Medical Entomology and Zoology · Cited by 108
FK463, a Novel Water-soluble Echinocandin Lipopeptide. Synthesis and Antifungal Activity.
Tomishima, M., Ohki, H., Yamada, A., Takasugi, H., Maki, K., Tawara, S., & Tanaka, H. (1999) · The Journal of Antibiotics · doi:10.7164/antibiotics.52.674 · Cited by 107
Frontiers in Marine Biotechnology
Proksch, P., & Müller, W. E. G. (2006) · Cited by 106
Shuttleworth, S. J., Silva, F. A., Cecil, A., Tomassi, C., Hill, T., Raynaud, F. I., Clarke, P. A., & Workman, P. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796011229 · Cited by 104
SGLT2 inhibitors: molecular design and potential differences in effect
Isaji, M. (2011) · Kidney International · doi:10.1038/ki.2010.511 · Cited by 104
Simple compounds, 2-alkyl-2-amino-1,3-propanediols have potent immunosuppressive activity
Fujita, T., Yoneta, M., Hirose, R., Sasaki, S., Inoue, K., Kiuchi, M., Hirase, S., Adachi, K., Arita, M., & Chiba, K. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00126-e · Cited by 101
L-671,329, a new antifungal agent. I. Fermentation and isolation.
SCHWARTZ, R. E., GIACOBBE, R. A., Bland, J. A., & Monaghan, R. L. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.163 · Cited by 100
Regulation of Glucose Transporters in LLC-PK1 Cells: Effects of D-Glucose and Monosaccharides
Ohta, T., Isselbacher, K. J., & Rhoads, D. B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6491 · Cited by 98
Kirschning, A., Taft, F., & Knobloch, T. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b709549j · Cited by 97
Structural selectivity of human SGLT inhibitors
Hummel, C. S., Lü, C., Liu, J., Ghezzi, C., Hirayama, B. A., Loo, D. D. F., Kepe, V., Barrio, J. R., & Wright, E. M. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00328.2011 · Cited by 97
Tsujihara, K., Hongu, M., SAITO, K., Inamasu, M., ARAKAWA, K., Oku, A., & MATSUMOTO, M. (1996) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.44.1174 · Cited by 96
Reevaluation of renal tubular glucose transport inhibition by phlorizin analogs
Vick, H. A., Diedrich, D., & Baumann, K. (1973) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1973.224.3.552 · Cited by 92
Biosynthesis of rapamycin and its regulation: past achievements and recent progress
Park, S. R., Yoo, Y. J., Ban, Y. H., & Yoon, Y. J. (2010) · The Journal of Antibiotics · doi:10.1038/ja.2010.71 · Cited by 90
Deacylation of echinocandin B by Actinoplanes utahensis.
BOECK, L. V. D., Fukuda, D. S., Abbott, B. J., et al. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.382 · Cited by 89
Cited by
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Counting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Self-citationMartins, A., Vieira, H., Gaspar, H., & Santos, S. (2014) · Marine Drugs · doi:10.3390/md12021066 · Cited by 572
Green Chemistry in the Synthesis of Pharmaceuticals
Kar, S., Sanderson, H., Roy, K., Benfenati, E., & Leszczynski, J. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00631 · Cited by 566
Metadata
- Authors
- Bauer, A., & Brönstrup, M.
- Venue
- Nat. Prod. Rep.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 31
- Issue
- 1
- Pages
- 35-60
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2153659956
- Cited by
- 255
- References
- 302
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.